Master of Pharmaceutical Medicine

Orin Chisholm

Associate Professor Orin Chisholm

BSc (Hons), GCULT,;PhD, SFHEA

Program Authority and Associate Professor in Pharmaceutical Medicine, School of Medical Sciences, UNSW Sydney

Orin Chisholm is the Program Director and Associate Professor in Pharmaceutical Medicine in the School of Medical Sciences at UNSW.

Orin is a member of the Gene Technology Technical Advisory Committee which provides advice to the Gene Technology Regulator and the OGTR on all matters relating to gene technology, genetically-modified organisms (GMOs) and genetically modified (GM) products. She is an adjunct faculty member of the Edson College of Nursing and Health Innovation, Arizona State University, USA.

She has extensive experience in the pharmaceutical industry, which has equipped her to embed practical, current and innovative education in pharmaceutical medicine in her role as program director. She has worked predominantly in regulatory affairs in both large multinational pharmaceutical and smaller biotechnology companies in Australia.   She has particular expertise in the registration of biotechnology products for oncology indications. She contributes her expertise in global regulatory affairs as a reviewer for Therapeutic Innovation and Regulatory Science and Frontiers in Pharmacology.  She is Chair of the ANZ Regional Advisory Committee for DIA and is a member of the Editorial Advisory Committee for RAPS.

Orin also has a strong academic background in the molecular biology of haemopoiesis and oncology and she has teaching qualifications in higher education. She has received a Faculty teaching award for outstanding contributions to student learning, a TOPRA award for Regulatory Affairs Education and is a Senior Fellow of the Higher Education Academy of the UK. 

For Orin's publications, please see her research profile.

Orin is a member of ARCS, ASCEPT, DIA, RAPS, TOPRA and HERDSA.

Please follow Orin on LinkedIn and Twitter

 


Dr Johnson Liu

BSc, GCULT, MSc, PhD

Lecturer, Pharmaceutical Medicine and Pharmacology, School of Medical Sciences, UNSW Sydney

Johnson Liu is a member of Human Research Ethics Committee of South Eastern Sydney Local Health District which review and approve applications for human research activities to ensure the highest standard of integrity in research. Johnson has educational qualifications in higher education with extensive teaching experience for both undergraduate and postgraduate programs, especially in pharmaceutical sciences, pharmacology, medicines development, clinical trials and regulations. Johnson has served academic positions at University of Auckland, Auckland University of Technology, University of Tasmania and currently UNSW Sydney.

Johnson has research interests in cancer pharmacology, drug transporters, targeting cancer cell signaling pathways, pharmacokinetics, drug development, systems pharmacology and chemotherapy-induced neuropathy, with support from public and commercial funding bodies, such as Cancer Council Tasmania and the New Zealand Cancer Society. He has published over 40 peer-reviewed research articles and serves as a review editor and manuscript reviewer for international journals. He is a member of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT) and the American Association of Cancer Research (AACR). He has supervised over a dozen postgraduate research students.
 

For Johnson's publications, please see his research profile.